AG-636
CAS No. 1623416-31-8
AG-636( —— )
Catalog No. M23718 CAS No. 1623416-31-8
AG-636 is a potent, reversible, selective and orally active DHODH inhibitor(IC50 of 17 nM). It has strong anticancer effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 149 | In Stock |
|
10MG | 246 | In Stock |
|
25MG | 500 | In Stock |
|
50MG | 718 | In Stock |
|
100MG | 981 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAG-636
-
NoteResearch use only, not for human use.
-
Brief DescriptionAG-636 is a potent, reversible, selective and orally active DHODH inhibitor(IC50 of 17 nM). It has strong anticancer effects.
-
DescriptionAG-636 is a potent, reversible, selective and orally active DHODH inhibitor(IC50 of 17 nM). It has strong anticancer effects.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorDHODH;DNA/RNA Synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1623416-31-8
-
Formula Weight343.4
-
Molecular FormulaC21H17N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:31.25 mg/mL (91.01 mM; Need ultrasonic)
-
SMILESO=C(C1=C(N(C)N=N2)C2=CC(C3=CC=C(C4=CC=CC=C4C)C=C3)=C1)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gabrielle McDonald, et al. Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase. Mol Cancer Ther. 2020 Dec;19(12):2502-2515.
molnova catalog
related products
-
AG-120 (racemic)
AG-120 (racemic), the racemic mixture of AG-120, is an orally available isocitrate dehydrogenase type 1 (IDH1) inhibitor, and shows potential antineoplastic activity.
-
CVT-11127
CVT-11127 is an StearoylCoA Desaturase-1 (SCD1) inhibitor.
-
Tenuifoliside B
Tenuifoliside B is a natural?product from? the roots of Polygala tenuifolia.And is?a target lactate dehydrogenase inhibitor.?Tenuifoliside B has cognitive improving and cerebral protective effects.?it can inhibit potassium cyanide (KCN)-induced hypoxia and scopolamine-induced memory impairment in mice.